Search

Search Constraints

You searched for: Author/Creator Herbst, Rudolf

Search Results

1. Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG. Issue 4 (7th April 2023)

2. Characterisation and outcome of RAC1 mutated melanoma. (April 2023)

3. Clinical Models to Define Response and Survival With Anti–PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma. Issue 10 (1st April 2022)

4. Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients. Issue 1 (26th March 2020)

5. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Issue 6 (June 2016)

6. Electrochemotherapy in advanced skin tumors and cutaneous metastases – a retrospective multicenter analysis. (April 2015)

7. Elektrochemotherapie bei fortgeschrittenen Hauttumoren und Hautmetastasen – eine retrospektive multizentrische Auswertung. (April 2015)

8. Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG. Issue 1 (5th May 2020)

9. Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. Issue 6 (10th June 2022)

10. MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – An evaluation of the multicenter prospective skin cancer registry ADOREG. (May 2022)